UPDATE – BioIntelliSense Launches New BioButton® Rechargeable Wearable Device for Continuous Medical Grade Monitoring of 20+ Vital Signs and Biometrics
15. März 2022 12:54 ET
|
Biointellisense, Inc.
DENVER, March 15, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, expands its commitment to creating a new standard of remote patient...
BioIntelliSense Launches New BioButton® Rechargeable Wearable Device for Continuous Medical Grade Monitoring of 20+ Vital Signs and Biometrics
15. März 2022 08:00 ET
|
Biointellisense, Inc.
DENVER, March 15, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, expands its commitment to creating a new standard of remote patient care...
BioIntelliSense and UAE-based Mubadala Health Establish Strategic Collaboration to Enable Continuous Care Model for Medical Grade Remote Monitoring and Management
02. März 2022 07:00 ET
|
Biointellisense, Inc.
DENVER and ABU DHABI, United Arab Emirates, March 02, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced today its strategic...
Joerns Healthcare and BioIntelliSense Announce North American Partnership to Expand Access to Innovative, Medical Grade Wearable Devices for Continuous Remote Monitoring, Enabling Patient Care Anywhere
16. November 2021 10:00 ET
|
Biointellisense, Inc.
CHARLOTTE, N.C. and DENVER, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Joerns Healthcare, a healthcare technology and equipment services company, announced today that they have entered into a strategic...
Myia Health and BioIntelliSense Partner to Integrate Continuous Vital Sign Monitoring Into the Myia Platform
14. Oktober 2021 08:00 ET
|
Biointellisense, Inc.
SAN FRANCISCO and DENVER, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Myia Health, an enterprise platform for virtual health care delivery in the home, and BioIntelliSense, a continuous health monitoring and...
BioIntelliSense Honored by Goldman Sachs for Entrepreneurship
13. Oktober 2021 09:00 ET
|
Biointellisense, Inc.
DENVER, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Goldman Sachs (NYSE:GS) is recognizing BioIntelliSense for Entrepreneurship and Founder and CEO, James Mault, MD, as one of the 100 Most Intriguing...
Jasper Health and BioIntelliSense Form Strategic Collaboration to Transform Remote Monitoring for Oncology Care
26. August 2021 08:00 ET
|
Biointellisense, Inc.
Jasper Health will integrate the BioIntelliSense FDA-cleared BioSticker™ and medical grade BioButton® wearable devices as part of its remote member engagement and guidance platformJasper Health and...